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STUDY PROTOCOL Open Access
Muslim Communities Learning About
Second-hand Smoke in Bangladesh
(MCLASS II): study protocol for a cluster
randomised controlled trial of a community-
based smoke-free homes intervention, with
or without Indoor Air Quality feedback
Noreen Mdege1* , Caroline Fairhurst2, Tarana Ferdous3, Catherine Hewitt2, Rumana Huque3,4, Cath Jackson5,
Ian Kellar6, Steve Parrott1, Sean Semple7, Aziz Sheikh8, Shilpi Swami1 and Kamran Siddiqi1,9
Abstract
Background: Second-hand smoke (SHS) is a serious health hazard costing 890,000 lives a year globally. Women
and children in many economically developing countries are worst affected as smoke-free laws are only partially
implemented and homes remain a major source of SHS exposure. There is limited evidence on interventions
designed to reduce SHS exposure in homes, especially in community settings. Following a successful pilot, a
community-based approach to promote smoke-free homes in Bangladesh, a country with a strong commitment
to smoke-free environments but with high levels of SHS exposure, will be evaluated. The study aims to assess the
effectiveness and cost-effectiveness of a community-based intervention, Muslims for better Health (M4bH), with or
without Indoor Air Quality (IAQ) feedback, in reducing non-smokers’ exposure to SHS in the home.
Methods/design: Based on behaviour-change theories, M4bH and IAQ feedback are designed to discourage
people from smoking indoors. M4bH consists of a set of messages couched within mainstream Islamic discourse,
delivered weekly by faith leaders (imams and khatibs) in mosques over 12 weeks (one message each week). The
messages address key determinants of current smoking behaviours including lack of knowledge and misconceptions
on specific harms associated with SHS exposure. IAQ feedback consists of personalised information on IAQ measured
by a particulate matter (PM2.5) monitor within the home. Following adaptation of M4bH and IAQ feedback for the
Bangladeshi context, a three-arm cluster randomised controlled trial will be conducted in Dhaka. Forty-five mosques
and 1800 households, with at least one smoker and one non-smoker, will be recruited. Mosques will be randomised
to: M4bH and IAQ feedback; M4bH alone; or usual services only. The primary outcome is 24-h mean household
concentration of indoor fine particulate matter (PM2.5) at 12months post randomisation. Secondary outcomes are
24-h mean household PM2.5 at 3 months post randomisation, frequency and severity of respiratory symptoms,
health care service use and quality of life. A cost-effectiveness analysis and process evaluation will also be conducted.
(Continued on next page)
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Discussion: The MCLASS II trial will test the potential of a community-based intervention to reduce second-hand
smoke exposure at home and improve lung health among non-smokers in Bangladesh and beyond.
Trial registration: ISRCTN, ISRCTN49975452. Registered on 11 January 2018.
Keywords: Second-hand smoke, Indoor air-quality feedback, Smoke-free homes, Bangladesh, Muslims, Mosque, Imams,
Khatibs, Cluster randomised controlled trial
Background
Second-hand smoke (SHS) contains 4000 toxic chemi-
cals and is a serious health hazard to non-smokers.
Every year, an estimated 890,000 people die and 10·9
million disability-adjusted life years (DALYs) are lost due
to SHS exposure, worldwide [1, 2]. A significant propor-
tion of this disease burden (40% deaths and 70% DALYs
lost) is due to respiratory conditions, e.g. asthma, chest
infections, and lung cancer [3]. Women and children are
worst affected: 47% of deaths from SHS exposure occur
in female adults and 28% in children [3]. SHS increases
children’s risk of acquiring lower respiratory tract infec-
tions [4–6], tuberculosis [7, 8], and incident cases, recur-
rent episodes, and exacerbations of asthma [9]. Parental
smoking is also associated with an increased risk of their
children’s admissions to hospital [5]. Children living in
smoking households are at high risk of becoming adult
smokers later [10].
Recognising SHS as a public health threat, comprehen-
sive smoke-free legislation is in place in 55 countries
worldwide, including 35 low- and middle-income coun-
tries (LMICs), and covers almost 1.5 billion people (20%
of the world’s population) [2]. In countries where these
bans are comprehensive and strictly enforced, this has
led to significantly reduced exposure to SHS and its as-
sociated morbidity and mortality [1, 11]. However, com-
pliance to the comprehensive smoke-free legislation is
problematic, with only 22 (40%) out of the 55 countries
having high compliance rates [2]. In many LMICs smok-
ing bans are only partially implemented. The southeast
Asia region, which includes Bangladesh, has the highest
burden of disease attributable to SHS in the world.
According to the Global Youth Tobacco Survey (GYTS
2007) and Global Adult Tobacco Survey (GTAS 2009),
40% of people living in Bangladesh are exposed to SHS
[12, 13]. A recent survey in 12 schools in Dhaka,
Bangladesh found that 95% (453/479; 95% CI 92.2 to
96.4) of 9–11-year-old children had saliva cotinine levels
consistent with recent exposure to SHS [14]. In total,
43% (208/479) of children lived with at least one smoker,
and those living with a smoker had a mean cotinine
value approximately double (β = 1.97; 95% CI 1.67 to
2.36) that of those not living with smoker(s) [14]. This
indicates that homes remain a key source of SHS
exposure in children in Bangladesh.
There is limited high-quality evidence on the effect-
iveness of interventions that reduce SHS exposure in
homes [15], especially in community settings in
LMICs. A recent Cochrane review concluded that
despite several studies on parental education and
counselling programmes, their effectiveness in redu-
cing children’s tobacco smoke exposure has not been
clearly demonstrated [15]. Other reviews [16–18] have
also highlighted limited evidence and have advocated
for better research investigating the effectiveness of
such interventions.
This research focusses on community-based ap-
proaches to protect non-smoking adults and children
from the harms of SHS in their homes. The proposal
builds on the findings of a pilot trial conducted in
England [19], which concluded that a Smoke-Free
Homes (SFH) intervention was acceptable to Muslim
communities and feasible to deliver in mosques [20]. It
was also possible to recruit, randomise and retain mos-
ques and participant households. There are two other
trials (either completed or on-going) in Bangladesh: one
evaluating a school-based, smoke-free intervention to
encourage children to negotiate smoking restrictions in
their households, relying on children as change agents
[21]; and another evaluating a multicomponent interven-
tion to reduce home-exposure to SHS during pregnancy
in Bangladesh and India (IMPRESS study), relying on
pregnant women as change agents [22, 23]. In the
present trial, the intervention is directly targeted at
smokers (mostly men) working through faith leaders
(imams and khatibs) and by providing Indoor Air
Quality (IAQ) feedback. IAQ feedback has been used
successfully with smoking parents of young children in
studies in Scotland [24] and in England [25].
Methods/design
Aim
This study will evaluate whether a community-based
intervention called Muslims for better Health (M4bH)
in which imams and khatibs will be trained to en-
courage their congregations in mosques to change
their smoking behaviours, with or without IAQ feed-
back, is effective and cost-effective in reducing SHS
exposure in the home.
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Research objectives
The specific research objectives address effectiveness
and cost-effectiveness questions (primary objective) as
well as implementation questions (secondary objectives).
Primary objective
a. To investigate the effectiveness and cost-effectiveness
of a community-based intervention – M4bH – with
or without IAQ feedback, in reducing (i) non-
smokers’ exposure to SHS in the home, (ii) frequency
and severity of respiratory symptoms, and (iii) health
care service use; and in (iv) improving quality of life.
Secondary objectives
b. To identify the mechanisms and contextual factors
that are likely to influence the impact of M4bH and
IAQ feedback
c. To estimate the likely costs and effects of scaling up
M4bH with and without IAQ feedback
d. To develop a simple monitoring framework, that
could be efficiently employed as the intervention(s)
are scaled up, and
e. To identify the likely obstacles to, and opportunities
for, implementing and scaling up the intervention(s)
and how best to work with communities and policy-
makers to overcome the obstacles and maximise the
opportunities
Study design
We will employ an effectiveness-implementation hybrid
study design [26] that blends components of effective-
ness and implementation research. The study thus
consists of three components: (i) effectiveness and
cost-effectiveness evaluation (objective a); (ii) process
evaluation (objectives b and e); and (iii) implementation
and scale-up (objectives c-e ). The study will be
conducted over 27 months in total (18 months for
(i) and (ii), 6 months for (iii) and another 3 months for
analysis and write-up).
Figure 1 shows the design of the trial comprising
effectiveness, cost-effectiveness and process evaluation.
Effectiveness and cost-effectiveness evaluation
A pragmatic, three-arm, open-label, cluster randomised
controlled trial (cRCT) with concurrent economic evalu-
ation will be conducted over 18 months in 45 mosques
and their catchment communities in Mirpur area of
Dhaka, Bangladesh. The three trial arms are as follows:
Arm 1: M4bH intervention and IAQ feedback
Arm 2: M4bH intervention alone
Arm 3: Usual services
Intervention description
The interventions have been co-produced with Muslim
religious leaders and public health experts in
Bangladesh, through an iterative process of adaptation of
the SFH intervention developed as part of the MCLASS
pilot trial (MR/J000248/1) [19] to the Bangladesh con-
text. IAQ feedback, piloted in Scotland [24] and cur-
rently undergoing method development as part of a
Medical Research Foundation (MRC) Public Health
Intervention Development grant (MR/M026159/1) has
also been adapted. These adaptations have been in-
formed by: (1) findings of the qualitative study in the
first phase of the IMPRESS study (MR/N006224/1) con-
ducted in Bangladesh and India [23]; and (2) findings
from Phase I of the MCLASS II study, which included
30 in-depth interviews with adults in households (a mix
of men who smoke in the home/no longer smoke in the
home and women whose husbands smoke in the home/
no longer smoke in the home) in Dhaka, three focus
group discussions with imams and khatibs in Dhaka,
and five intervention development workshops with
representatives of Ministry of Religious Affairs, Islamic
Foundation (IF), Imam Training Academy, imams, khatibs,
muftis and public health experts in Dhaka.
For each cluster (mosque), the intervention period will
last for 3 months after randomisation.
M4bH intervention Culturally adapted to a Bangladeshi
context, M4bH consists of a set of messages couched
within mainstream Islamic discourse, delivered by
imams and khatibs in mosques over 12 weeks (one mes-
sage for each week). The messages address key determi-
nants of current smoking behaviours including: lack of
knowledge on, and attitudes towards, smoking and SHS
exposure by providing information on health conse-
quences of smoking and SHS exposure including ad-
dressing any misconceptions; and perceptions about
social norms by providing general information on others’
approval. The messages also target the following:
prompting intentions; goal setting (both for behav-
iour, e.g. quit attempt, and the desired outcome of
SFH), self-efficacy, commitment, action planning,
coping planning, and sources of social support. Each
of the messages is supported by at least one verse
(ayah) from the Qur’an, or Islamic faith-based de-
cree including those on addiction, hygiene, health
promotion, self-harm and inflicting harm to others,
and sanctity of human life (see examples in Table 1
below). The M4bH intervention messages will be de-
livered to men attending Friday (Juma) prayer con-
gregations in mosques.
Imams and khatibs allocated to intervention arms 1
and 2 will receive a half-day training on delivering the
M4bH intervention to their congregations using a set of
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training materials designed specifically for this trial.
They will also be provided with a M4bH intervention
booklet/guide detailing each message and the supporting
verses (ayahs) from the Holy Qur’an and/or hadith and
the order with which the messages are to be delivered
over the 12 weeks, to support them in delivering the
messages within mainstream Islamic discourse. Imams
and khatibs in mosques randomised to arms 1 and 2 are
also given copies of the M4bH intervention booklet to
distribute to members of their congregation after Friday
prayers or in study circles, as they feel appropriate.
IAQ feedback intervention The IAQ feedback inter-
vention will be provided to households in arm 1 of the
trial, and will comprise personalised information on the
IAQ measured within their home at baseline, in the
form of a two-page IAQ feedback leaflet, in order to mo-
tivate changes in smoking behaviour in households. The
information will be based on data gathered at baseline
using a monitor called the Dylos DC1700 (Dylos, River-
side (CA), USA). The first page of the IAQ feedback
leaflet will contain information on the total indoor fine
particulate matter less than 2.5 μm in diameter (PM2.5)
Fig. 1 MCLASS II trial flow diagram
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concentration measurement time in their home, the mean
PM2.5 concentration which will be compared to the World
Health Organisation (WHO) guidance limit of 25 μg/m3
[27], the total time the IAQ was above this guidance limit,
and maximum level measured. Based on the Phase-I
findings, the feedback leaflet will also have a line graph
representing the hourly fluctuations in the indoor PM2.5
concentrations within the home with a line representing
the WHO guidance limit as a reference, and colour codes
summarising levels of particulate matter during 1-h
periods (classified as high, moderate or safe) (Fig. 2).
The second page will have pictorial information about
the level of 24-h mean PM2.5 concentration of that par-
ticular home (with classifications hazardous if PM2.5
concentration is > 150 μg/m3, unhealthy if 36–150 μg/
m3, moderate if 12–35 μg/m3, and good if < 12 μg/m3),
information about the adverse effects of SHS exposure,
recommendations to reduce SHS exposure in the home,
and a target that is achievable by implementing SFH
rules within that home. This will be accessible to indi-
viduals with a diverse range of literacy and numeracy
skills. Trial field investigators (FIs) will deliver and dis-
cuss the IAQ feedback with members of the households
in person and answer any question raised, which may
take approximately 10 min.
Follow-up IAQ measurements will take place at 3
months and 12 months in 30 homes per mosque where
high levels of SHS (≥ 35 μg/m3) were identified at base-
line, plus a small number of households under this
threshold if necessary. All followed up homes in all trial
arms will receive details of their month-12 IAQ mea-
surements and feedback after trial completion.
Usual service No intervention will be offered to mos-
ques randomised to the usual service arm until the trial
has completed. Following the completion of the pilot
trial, mosques will be offered the M4bH toolkit free of
charge.
Recruitment
We aim to enrol 45 mosques (15 in each arm) and 1800
households (40 from each mosque catchment area) into
the trial.
Mosque eligibility criteria A mosque will be eligible if
it:
 Is based in the residential parts of Mirpur, Dhaka
 Hosts communal prayers (including Friday prayers)
Table 1 Examples of M4bH intervention messages and supporting ayahs
Ayah Constructs Message Behaviour-change techniques [43]
Surah An-Nisa – 59 (4:59)
O you who have believed, obey
Allah and obey the Messenger
and those in authority among
you
Attitude Wise people like Alims all agree that smoking
and indirect smoking are harmful for all.
Scientists have also found that there are about
70 types of chemicals in the smoke from
second-hand smoking that can cause cancer.
Second-hand smoking can also lead to many
health problems in newborns and children.
Therefore, we have to follow the Prophet’s way
to warn ourselves and to warn others, and also
listen to wise people
9.1. Credible source
5.1. Information about health
consequences
5.2. Salience of consequences
5.6. Information about
emotional consequences or
5.3. Information about social and
environmental consequences
Surah At-Baqara – 195 (2:195)
And do good; indeed, Allah loves
the doers of good
Social norms Those who smoke around us unintentionally
harm others directly. Thus, every year 600,000
people die due to exposure to passive smoking
worldwide. So, we have to be aware of passive
smoking and be careful about smoking inside
home and in front of others. We also need to
share these messages with others. We must
keep ourselves and our families safe from the
harm of passive smoking. Allah also loves those
who do good things
6.1. Information about others’
approval
5.1. Information about health
consequences
5.2. Salience of consequences
5.6. Information about
emotional consequences or
5.3. Information about social and
environmental consequences
Surah Ar-Ra’d – 11 (13:11)
Allah will not change the condition
of a people until they change what
is in themselves
Self-efficacy (prompt
action planning)
You can ask Allah for help to change your
situation. But before getting help from Him, we
need to take action first. Then, believe that Allah
will give you the desired results.
It might be difficult for you to stop smoking at
home. But will you not do this little thing for
the welfare of your family members? How can
you then ask God for helping you and your
family?
So, you just have to take a small step. That is,
if you feel the need to smoke whilst at home,
go outside the home to smoke
3.1. Social support (unspecified)
1.4. Action planning
1.9. Commitment
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 Is at least half a kilometre from another
participating mosque
 Has an imam or khatib who is a self-reported non-
smoker
 Is enlisted with the Islamic Foundation (IF).
These mosques will be under a government
ministry and will be monitored by the
government
A mosque will not be eligible if it:
 Is located in an area with restricted access such that
it is difficult to get in and recruit households
 Has too small a catchment area to recruit at least 40
households from
 Does not have an imam or khatib who is
willing to participate and deliver the M4bH
intervention
Household eligibility criteria For this trial, a household
is defined as a single housing unit shared by one or
more individuals.
For a household to be eligible for the trial, it should:
 Have at least one resident attending one of the
participating mosques
 Have at least one adult resident who smokes
cigarettes or other forms of smoked tobacco (e.g.
bidi, waterpipe) regularly (at least 25 out of 30 days/
month)
 Have at least one non-smoking resident of any age
 Not be planning to move home in the next 12
months
In circumstances where two or more families share a
housing unit and stay together they will be enrolled as
one household if all family heads agree to participate.
The families will have to agree who would be the house-
hold lead for the trial.
A resident is defined as an adult or child who has
been staying in the home for at least the previous 3
months and plans to stay for at least one more year
in the home.
A household will not be eligible if:
 It uses coal and/or biomass fuel for domestic use
 The household head/lead is unwilling/unable to give
written informed consent
Fig. 2 Indoor Air Quality (IAQ) feedback graph
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 One or more families in a shared housing unit do
not want/do not agree to participate
Mosque recruitment FIs will collect Global Positioning
System coordinates for mosques that are IF enlisted.
Those that are more than half a kilometre away from an-
other participating mosque will be approached via chairs
of their respective committees and other relevant leaders
(e.g. ward commissioners) to seek their expression of
interest in participating in the MCLASS II trial. Existing
links with the IF, including its local community officers,
as well as links with mosque committee members will
be used in making the initial contact. All interested mos-
ques will be visited and their committee chairs and
leaders met to inform them about the trial including
explaining random allocation and its purpose. If inter-
ested in trial participation, mosques will be screened for
eligibility and provided with an information sheet in-
cluding: the aims and objectives of the trial; a descrip-
tion of the trial interventions and trial arms; details
about the randomisation process; the role of the mosque
and imams/khatibs in the trial; withdrawal processes;
risks, advantages and disadvantages of participating; how
the results will be used; and confidentiality issues.
Mosque agreement to participate Agreement to par-
ticipate in the trial will be sought from the mosque
imam/khatib by FIs. They will be asked to sign a written
agreement to participate for their mosque and them-
selves. This approach is considered to be reasonable
given the organisational structures within mosques
based on the MCLASS pilot trial findings [19].
Agreement to participate will be sought for:
 Implementing the M4bH intervention in the
mosque, should that mosque be allocated to one of
the M4bH groups
 Facilitating the research team (recruitment officers)
in the recruitment of participants in the respective
mosque catchment area
 Approaching mosque imams and khatibs to seek
their consent to take part in interviews, and
 Recording of non-identifiable mosque data according
to the trial protocol
Household recruitment Local researchers will approach
Muslim community household heads, generally men, liv-
ing in the catchment area and attending prayers in the
participating mosques. Local researchers will be supported
in the field by supervisors and caretakers of the IF who
work in the area and are known to the community.
A number of strategies will be used to recruit
participants:
1. We will provide imams, khatibs or any other
relevant persons from the mosque with a written
script that they will use in announcements to
inform members of their congregation about the
study
2. At the end of Friday sermons (just before the Friday
prayer), imams/khatibs will introduce an MCLASS
II researcher who will introduce the trial to the
audience in less than 5 min
3. The FIs, with the support of the imams, will also
visit households in the catchment areas and provide
households with information about the study
Household eligibility assessment Each potential house-
hold will be allocated a unique screening number, which
will be used as their unique trial identifier (ID) if en-
rolled in the trial. The participating household members
will also receive trial IDs that will be unique for each
participant but will include the household number so as
to be able to identify participants from the same house-
hold. The following anonymised household screening in-
formation will be collected: mosque attended and
eligibility for inclusion using the eligibility criteria de-
scribed above.
The following will be recorded for those eligible:
 Consented
 Declined
 Reason for declining, if given
For those not eligible for the trial, the reason for ex-
clusion will be recorded.
Informed consent for households and participants
Since the M4bH intervention is to be delivered in the
mosque, agreement for delivering the intervention will
be sought from the mosque imams and khatibs and not
from individual participants. This approach is propor-
tionate given the very low risk associated with participa-
tion and the likely potential benefits of the intervention.
However, written informed consent will be sought from
all adult participants in the household for all other re-
search activities.
Based on the main eligibility criteria, i.e. households
with at least one adult resident who smokes cigarettes or
other form(s) of smoked tobacco (e.g. bidi, waterpipe)
and at least another non-smoking resident of any age,
eligible households will fall into two possible categories:
 Households with at least one adult smoker and one
child: In this case, consent will be sought from all
the adult residents for completing the baseline (and
follow-up when requested) questionnaire. Consent
will also be sought from parents/guardians of any
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child aged below 18 years old, to collect baseline
(and follow-up when requested) data on the child
 Households with adult residents only including at
least one smoking and one non-smoking adult:
consent will be sought from all adult residents
for completing the baseline (and follow-up when
requested) questionnaire
Consent will also be sought from the household
head/lead for the participation of the household, in-
cluding IAQ measurement which will involve install-
ing the Dylos DC 1700 for at least 24 h in their
homes before and at 3 and 12 months after random-
isation. Installation will involve plugging the meter
into the electricity mains in the living area of the
house (excluding the kitchen) most commonly used
by family members.
FIs will go through the respective information sheet
with potential participants during their appointment
and seek consent(s) as appropriate. Participants are
not offered any personal incentive for taking part in
the trial; however, each household will receive Taka
200 (GBP 2) at baseline and the 12-month follow-up
time point, to compensate for the time they are giv-
ing, and to cover expenses associated with powering
the air-quality monitors in their home for 24 h on up
to three occasions.
Informed consent will be obtained prior to registration
of participants and before any trial-specific baseline
assessments.
Household and participant registration For all indi-
viduals who have expressed an interest and are, there-
fore, approached for potential inclusion, the following
non-identifiable data will be recorded in secure trial
databases: mosque attended; date of birth; gender;
smoking status; eligibility criteria; consent given/refused;
and reasons for not consenting (if given). The time taken
for screening will also be recorded.
All consenting individuals (and households) will be
registered in a secure trial database, using their name,
date of birth, address, and unique trial ID (both for
households and individuals). Only the chief investiga-
tor, trial coordinator, and researchers involved in
collecting, quality checking and entering data will
have access to these identifiable data at any stage of
the trial. For the purpose of baseline and follow-up
data collection and conducting analyses, only the
unique trial ID will be used, thereby ensuring anonymity
of data.
Paper consent and agreement to participate forms will
be kept in a locked filing cabinet at the ARK Foundation
in Dhaka, separate from the rest of the trial data.
Baseline assessments
Mosque baseline assessment For each mosque partici-
pating in the trial the following information will be re-
corded at the start of the trial:
 Catchment area
 Type of mosque (ethnic and religious denomination)
 Average estimate of number of people who attend
two or more daily prayers
 Average estimated size of Friday congregation
 Average estimated size of study circle (men)
 Average estimated size of Qur’an class
 Average age (self-reported by teacher) of students/
children taught
 Average estimated size of study circle (women)
A semi-structured questionnaire will be utilised to
measure the pre-intervention training knowledge of the
imams/khatibs on smoking and SHS exposure.
Participant (and household) baseline assessment
Baseline data will be collected from households, and all
consenting participants in the household, once informed
consent has been provided and before randomisation of
their mosque, using questionnaires.
The following data will be collected about the
household:
 Presence of outside space; number of bedrooms;
number of residents (adults and children);
number of resident smokers (adults and
children)
 Self-reported smoking restrictions, or lack thereof,
in the home
 Number of shops that sell tobacco products in
neighbourhood
 Presence of household amenities (e.g. electricity,
flush toilet, etc.)
 Type of fuel used for cooking
 Presence of mould/moisture in homes and any
damage caused
 Presence of cattle/pets/poultry in home
 Mosque attendance
IAQ of the household will also be measured at base-
line as 24-h mean levels of PM2.5 concentration using
the Dylos DC 1700 meter.
The following data will be collected about all consent-
ing participants in the household:
 Socio-demographic variables (date of birth, gender,
education)
 Self-reported smoking behaviour (≥ 11 years only)
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 St George’s Respiratory Questionnaire (SGRQ) ≥ 11
years; frequency and severity of respiratory symptoms
for under 11 year-olds
 Health service use
 Health-related quality of life: (EQ-5D-5 L for 18
years and over, Proxy version of the EQ-5D-Y: 1 for
11–17 year olds, PedsQL version 4.0 for under 11
year-olds)
 Attitudes, social norms, intentions and action
planning, self-efficacy, and coping planning with
regards to smoking and SHS exposure (≥ 18 years
only)
Randomisation process
Since the M4bH intervention is an ‘educational’ inter-
vention delivered at a group level, this trial is a cRCT
where mosques will be randomly allocated to one of the
three trial arms.
Mosque, household and participant recruitment, base-
line data collection and randomisation of the 45 partici-
pating mosques will be conducted over a period of 6
months. Once recruitment has ceased and mosque and
household baseline data collection are complete within a
particular mosque, the mosque will be randomly allo-
cated 1:1:1 to one of the three arms using minimisation
to ensure balance across the groups on the average esti-
mate size of the Friday prayer congregation (≤ 1500/>
1500) and geographical location (wards within the Mir-
pur area of Dhaka). Random allocation will be per-
formed by a statistician at the University of York not
involved in the recruitment of mosques or households,
thus ensuring allocation concealment.
Contamination and risk of bias
The process of randomisation will minimise the chance
of selection bias. There is a possibility that mosques/or
households in the control arms could be exposed to the
M4bH intervention. All mosques in the trial area will be
identified, including a list of mosques enlisted with the
IF. A geographical map of these potential mosques will
be prepared and Geographic Information System maps
used to ensure that the catchment areas of any two clus-
ters do not overlap. A buffer zone of half a kilometre be-
tween mosques will be used to minimise the risk of
contamination.
By the nature of the interventions used within this
trial, blinding of the participants and the imams and
khatibs delivering the intervention is not possible. Out-
come data collection and data analysis are also not
blinded.
In order to minimise loss to follow-up, the household
head/lead will be requested to inform the trial team of
any relevant changes in the household. FIs will also be in
regular contact with the household head/lead over the
phone. Households will be informed about follow-up
prior to the date. Information materials in the appropri-
ate language will be provided to ensure that participants
understand clearly what the expectations would be if
they decide and give consent to participate in the trial.
Withdrawal
Households and participants will be free to withdraw
consent and leave the trial at any time without giving a
reason. Written information on who to contact if they
wish to withdraw will be provided to all participants.
They will be able to withdraw by letting any member of
the research team know if they wish to do so. If a house-
hold or participant withdraws consent to participate, no
further data will be collected from them. However, data
collected up to the point of withdrawal will be retained
and used in the analysis, except where withdrawal of
consent for the use of this data is explicit, in which case
all data will be destroyed.
Sample size
Baseline air particulate data were considered for the
households recruited from the first six MCLASS II study
mosques to be randomised into the trial. Of the 240 re-
cruited, 222 households had at least 22 h of PM2.5 con-
centration measurement at baseline, with an average
PM2.5 of 66.5 μg/m
3. The United States (US) Environ-
mental Protection Agency (EPS) considers an Air Qual-
ity Index (AQI) of 101 (equivalent to 35 μg/m3) or more
to indicate unhealthy levels of air pollutants for sensitive
groups such as children and the elderly (https://airnow.
gov/index.cfm?action=aqibasics.aqi) [28]. Eighty percent
of the 222 households at baseline had an average 24 h
PM2.5 of 35 or more; among these households the mean
(standard deviation; SD) was 75.9 (44.2) μg/m3.
We propose to recruit 45 clusters (mosques) and 40
households with at least one resident smoker per cluster,
and shall follow up up to 30 households per mosque
with average baseline PM2.5 of 35 μg/m
3 or more. If
there are more than 30 households in the mosque with
average baseline PM2.5 of 35 μg/m
3 or more, then 30 will
be randomly selected for PM2.5 follow-up at 3 months,
with randomly selected reserves for those households
that are lost to follow-up at this time. If there are less
than 30 households in the mosque with average baseline
PM2.5 of 35 μg/m
3 or more, then the shortfall will be
made up of randomly selected households with PM2.5
under 35 μg/m3. The same households followed up at 3
months will be contacted for follow-up again at 12
months. We shall assume a 20% attrition rate at 12
months (the primary time point).
The intracluster correlation coefficient (ICC) for salivary
cotinine level was negligible in the MCLASS trial (< 0.01)
[19], but we shall assume an ICC of 0.02 in this trial to be
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conservative. With these figures, we would have 90%
power to detect an effect size of 0.3; this is equivalent to a
difference of 13.5 (e.g. from 76 μg/m3 to 62.5 μg/m3) as-
suming a SD of 45, between each intervention group and
the control group, using a two-sided 5% significance level.
In practice, we would expect to have greater than 90%
power with this sample size by virtue of adjusting the ana-
lysis for baseline PM2.5 concentrations, which we would
expect to be predictive of the follow-up measurement. We
have not accounted for this potential pre-post correlation
to ensure that the calculation is conservative, and to min-
imise the risk of the trial being underpowered. In the trial
analysis, we may wish to compare the two intervention
arms. The difference between these two arms is likely to
be much smaller than one we could expect to observe be-
tween one of the intervention arms and the control arm.
With these figures, we will retain 80% power to detect a
smaller effect size of 0.2 between the two intervention
groups, assuming a pre-post correlation of 0.6.
Outcomes
Post-randomisation outcome data will be collected from
households: (1) where 24-h mean PM2.5 levels are 35 μg/
m3 or above (we envisage approximately 75% (n = 30)
households per cluster) and (2) in a small random sample
of households where 24-h mean PM2.5 levels are below
35 μg/m3, as described in the ‘Sample size’ section.
Primary outcome The primary outcome will be 24-h
mean household indoor SHS concentration measured as
fine particulate matter less than 2.5 μm diameter (PM2.5)
at 12 months post randomisation.
PM2.5 will be measured in homes using the Dylos DC
1700 (Dylos, Riverside, CA, USA) a low-cost particulate
counter validated for use in domestic settings [29]. Data
from smokers’ homes in Scotland suggest that there is
little difference between PM2.5 levels measured on the
first day compared with levels measured over the follow-
ing period of up to 6 days. This suggests that installation
of these monitors for 24 h will provide a good represen-
tation of SHS levels within that home.
Setting up the Dylos: 24-h mean PM2.5 concentrations
will be calculated for each household before randomisa-
tion, and at 3 and 12 months post randomisation. Within
each household, the Dylos will be plugged into the elec-
tricity mains in the living area of the house (excluding
the kitchen) most commonly used by family members,
at least 1 m away from any doors, windows, or obvious
potential sources of PM2.5. The Dylos will be switched
on to start the logging process at the beginning of each
data collection period and will be left to measure and
log 1-min particle number concentrations for the dur-
ation. The monitors will be supplied with 6-h backup
batteries in case of power cuts or brown-outs. Devices
record IAQ every minute and enable estimation of SHS
concentrations with 1-min resolution over the sampling
period. The team is aware of the sensitivities of measur-
ing IAQ in homes and has experience of doing so in
various LMICs including Mexico, Pakistan, Indonesia,
Chad, Bangladesh, and India [30]. The team will work
closely with local partners to ensure that gender and cul-
tural practices are respected.
Analysing data from Dylos: data from the Dylos ma-
chine will be downloaded to a desktop portable com-
puter at the ARK foundation in Dhaka using the
AFRESH software version 4.2 at the end of each sam-
pling day. Dylos particle number concentrations will be
converted to equivalent PM2.5 mass concentrations and
corrected for non-linearity of response. Entry and exit
times for each venue will be matched to the sampling
day record sheets and an average PM2.5 concentration
will be calculated for each household. Feedback graphs
(Fig. 2) presenting baseline measurement data will be
generated to be used in the IAQ feedback component
for arm 1.
Secondary outcomes The following will be measured
for the household:
 SHS concentration measured as 24-h mean PM2.5
concentration at 3 months post randomisation
 Smoking restrictions at home: the level of smoking
restrictions at home will be assessed through a
questionnaire directed at the adults in the households
at 3, 6 and 12months post randomisation
The following will be measured for each member of
the household:
 Frequency and severity of respiratory symptoms: for
participants aged 11 years and over, Part 1 (eight
questions) of the validated SGRQ [31] will be used
to assess participants’ recollection of their
respiratory symptoms over the preceding month at
3, 6, and 12 months postrandomisation. SGRQ is a
validated questionnaire and a Bangla translation is
available for use. For participants younger than 11,
respiratory symptoms will be assessed by another
severity scale developed and validated by Chauhan
et al. [32] at 3, 6, and 12 months post randomisation
 Quality of life: at 3, 6, and 12 months post
randomisation the EQ-5D [33, 34] will be used for
adults 18 years and over, EQ-5D-Y [35, 36] for
adolescents (11–17 years inclusive) and PedsQoL
[37] for children aged below 11 years to measure
quality of life
 Health services use: a health service utilisation
questionnaire previously used in the MCLASS pilot
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trial [19], and adapted to the Bangladesh context,
will be used to collect number and type of contacts
with physicians, hospital admissions, pharmacy visits
and medication prescriptions for all participants.
This will be assessed at 3, 6, and 12 months’ follow-
up. The MCLASS pilot identified questionnaire
items with very low frequency of responses and
these questions are omitted from the MCLASS II
service use questionnaires
 Mediators of intervention effectiveness: mediators of
intervention effectiveness will be quantitatively
investigated focussing on those constructs that map
onto the intervention logic model that are: attitude,
social norms, intentions and action planning, self-
efficacy and coping planning with regards to
smoking and SHS exposure. These will be assessed
at baseline, and at 3, 6, and 12 months’ follow-up
using a pre-tested questionnaire, from adults (aged
18 years and over only)
In addition to socio-demographic variables, other con-
founders identified through the literature a priori will
also be measured including:
 Number of residents
 Building environment
 Neighbourhood
 Presence of mould/moisture in homes
 Use of gas for cooking or gas/kerosene/oil heater.
 Mosque attendance and receipt/participation in
M4bH programmes
The following will be measured for the imams and
khatibs who will deliver the trial intervention:
 Pre- and post-intervention training knowledge on
smoking and SHS exposure using a semi-structured
questionnaire
Frequency and duration of follow-up
Data will be collected at baseline, and 3, 6, and 12
months post randomisation as indicated in Fig. 3 below.
Data collection
A total of 16 FIs will screen, recruit households, and col-
lect baseline and follow-up information from 1800
households in 18 months. The FIs will receive 3 days’
training on trial procedures including taking informed
consent, administering and completing the question-
naires, delivering IAQ feedback, and ethical issues such
as autonomy of households and individual participants
on making decisions about participation, freedom to
withdraw from the trial without giving any reason or
consequence, privacy, confidentiality, anonymity. They
will work in pairs during recruitment and baseline data
collection for the first few mosques (approximately six
mosques) and then work individually with each FI work-
ing with one mosque at a time.
Data will be collected using paper-based question-
naires designed specifically for the trial. Collected data
will be quality checked and entered into the secure,
password-protected database designed specifically for
this trial on REDCap (Research Electronic Data
Capture), a secure web application for building and
managing online surveys and databases (https://projec
tredcap.org/software/). Collected data will be stored on a
central database server.
All data will be stored and transferred following
Health Insurance Portability and Accountability Act
protocol. The staff involved in the trial will be trained
on data protection processes. The staff will be strictly
monitored to ensure compliance with privacy standards.
Statistical analysis of effectiveness data
Analysis of clinical data The trial will be analysed and
reported according to the Consolidated Standards of
Reporting Trials (CONSORT) guidelines extension for
cluster trials [38]. A detailed statistical analysis plan has
been prepared and reviewed by an independent Trial
Steering Committee (TSC) prior to the completion of
outcome data collection. All analyses will be conducted
following the principles of intention-to-treat (ITT), in-
cluding all participating households within clusters in
the trial arm to which the cluster was randomised, using
two-sided statistical tests at the 5% significance level.
Summaries of the baseline characteristics of the clusters,
households and participants will be presented by trial
arm. Continuous measures will be reported using de-
scriptive statistics (e.g. n, mean, SD, median, minimum
and maximum) and categorical data as counts and per-
centages. No formal statistical comparisons by trial arm
will be undertaken on baseline data.
Screening recruitment, and retention data for mosques
and households will be summarised, and a CONSORT
flow diagram produced. Reasons for non-eligibility/par-
ticipation will be reported, where available. Follow-up
and withdrawal rates at each time point will be pre-
sented by randomised group, with reasons for with-
drawals given where available.
All outcome data will be summarised descriptively by
randomised group and time point.
Primary analysis Twenty-four-hour mean household
PM2.5 at 3 and 12months post randomisation will be
compared between the groups using a linear covariance-
pattern mixed model incorporating the two post ran-
domisation time points and controlling for pertinent
baseline covariates at the household and cluster level
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(including baseline PM2.5 value (household-level) and
the factors used in the minimisation (cluster-level)).
Clustering at the mosque level will be accounted for
using a random effect. The correlation of observations
within households over time will be modelled by a
covariance structure. The mean difference at 12 months
will serve as the primary outcome, and the difference at
3 months as a secondary outcome. Residuals will be
checked for normality and transformations for the
PM2.5 data (e.g. log) will be considered. Parameter
estimates and corresponding 95% confidence intervals
will be presented.
We hypothesise that a combination of the M4bH
intervention and IAQ feedback is more effective in im-
proving IAQ than usual services. Therefore, the compari-
son between the M4bH intervention plus IAQ feedback
(arm 1) and usual services (arm 3) will serve as the pri-
mary comparison, whilst the comparison between M4bH
intervention alone (arm 2) and usual services (arm 3), and
between M4bH intervention plus IAQ feedback (arm 1)
and M4bH intervention alone (arm 2), will serve as
secondary investigations.
Sensitivity analyses To account for non-compliance
with the intervention, a complier average causal effect
(CACE) analysis [39] will be considered which provides
an unbiased estimate of the treatment effect in the event
of non-compliance.
Secondary analyses Respiratory symptom questionnaire
scores from months 3, 6, and 12 will be analysed in
an analogous way as PM2.5 concentrations, with an
Fig. 3 Data collection schedule
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additional random effect for household if feasible.
Self-reported smoking behaviour and restrictions will be
summarised descriptively per arm.
To explore the potential for mediating mechanisms,
the primary analysis model will be repeated, but this
time including the mediator of interest as the outcome.
The primary analysis will then be repeated including the
mediator as a fixed effect. We will be looking for the
intervention effect being reduced and the mediator effect
being large. Further details including a full list of poten-
tial mediators to be explored will be pre-specified and
detailed in the statistical analysis plan. These analyses
will be exploratory and interpreted accordingly.
Analysis of economic and quality-of-life data
An incremental cost-effectiveness analysis will be con-
ducted to estimate the value for money afforded by the
M4bH intervention with and without IAQ feedback over
and above usual care.
Intervention costs The costs of providing M4bH with
and without IAQ feedback will be calculated. Costs will
include the staff time required to deliver the M4bH
intervention and the cost of materials used. Additional
costs in the IAQ feedback arm include the costs of the
Dylos DC1700 and the time taken to provide feedback
to the household.
Training costs The costs of training of individuals to
deliver the intervention will be calculated. Training
requires staff time of the trainer plus staff travel cost.
Staff time is based on the salary of the trainer and allo-
cated on a cost per minute basis plus costs of materials.
Training costs are divided by the number of trained
adults at each site. Training cost per adult benefits from
economies of scale whereby cost per adult decreases as
the number of adults trained increases at a site.
Health care utilisation Health care resource use data
for each participating member of the household will be
collected in all three trial arms at baseline and 3, 6, and
12 months’ follow-up. This data will allow the calcula-
tion of cost profiles for each individual based on local
unit costs of care which are multiplied by quantities of
resources consumed to calculate a per individual cost.
Quality-adjusted life years EQ-5D [33, 34] will be used
for adults aged 18 years and over, EQ-5D-Y [35, 36] for
adolescents (11–17 years) and PedsQoL (version 4) [37]
for children aged younger than 11 years at baseline and
3, 6, and 12 months’ follow-up to calculate changes in
Quality-adjusted Life Years (QALYs) for all household
members using local social tariff scores to derive health
utilities. QALYs will be calculated by using the area
under the curve between baseline and follow-up assum-
ing a linear change between recorded points [40].
Assessment of cost-effectiveness
Base case analysis The outcome for the cost-effective-
ness analysis will be QALYs at 12 months and the
cost-effectiveness analysis will be performed at this time
point. The costs will include intervention cost and the
cost of health resources during the 12-month period
post randomisation. QALYs will be calculated during the
same time period. An incremental cost-effectiveness
analysis will be performed to estimate the incremental
cost-effectiveness ratios (ICERs). Both costs and QALYs
will be combined to calculate the incremental cost per
QALY. ICERs will be calculated for M4bH and IAQ
feedback over and above usual care, M4bH intervention
only over and above usual care, and M4bH plus IAQ
compared to M4bH alone.
Uncertainty assessment Sensitivity analysis is con-
ducted by varying the cost components of the interven-
tion to estimate the robustness of the cost-effectiveness
ratios. Uncertainty around the decision to adopt the
intervention will be assessed through a non-parametric
bootstrap re-sampling technique. Bootstrapping has
been proposed as an efficient approach for calculating
the confidence limits for the ICER as its validity does
not require any specific assumptions with regard to the
underlying distribution. A cost-effectiveness acceptability
curve (CEAC) will be plotted based on the outcomes of
the 5000 bootstrap replications [41].
Interim analyses
No interim analyses will be conducted.
Process evaluation
The process evaluation will be carried out concurrently
with the effectiveness and economic evaluations. The
three key functions of a process evaluation for an effect-
iveness trial, identified by the MRC guidance for process
evaluation [42] – mechanisms of impact, context, and
implementation (including intervention fidelity) will be
explored as secondary outcomes.
Mechanisms of impact
To capture the views and experiences of participants, all
household head/lead participants in both intervention
arms whose homes have been included in the follow-up
sample will complete a short questionnaire at the end of
the intervention, as part of month-3 follow-up, exploring
which components of the M4bH intervention and IAQ
feedback they engaged with, the acceptability of each
component and any perceived benefits/non-benefits to
themselves and their families including those which were
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unanticipated. A purposive sample of 15–20 partici-
pants, a mix of men and women from households who
have/have not achieved SFH (based on PM2.5 scores) will
be interviewed to explore key issues that emerged in the
questionnaire; for example, any messages worded within
the mainstream Islamic discourse that were seen to be
particularly influential or inappropriate. Based on the
team’s previous experience, to avoid participant fatigue
with data collection, these interviews will be adminis-
tered a few days after the questionnaire.
Context and implementation
In six purposively selected mosques (a mix of those scor-
ing high and low on fidelity) the imams and khatibs who
delivered the intervention will be interviewed to explore
how contextual factors, such as the mosque environ-
ment and other social, economic, cultural, environmen-
tal and political factors, have influenced the delivery and
impact of the interventions. These in-depth interviews
will also explore implementation issues including per-
ceptions of the potential reach of M4bH, likely obstacles
and potential opportunities for scale-up of M4bH.
Intervention fidelity assessment
A fidelity index, mapped onto the behaviour-change
techniques [43] that underpin the M4bH intervention,
will be used to assess adherence to delivering the inter-
vention. Each mosque will deliver the intervention for a
maximum of 12 weeks. It is expected that there will be
at least 360 intervention sessions over this period (one
session per week × 12 weeks per mosque × 30 mosques).
The researcher(s) will perform the fidelity check on 10%
of the sessions (approximately 36 observation sessions in
total) by observing 50% of sessions in six randomly se-
lected mosques in the intervention arms (three mosques
per each intervention arm). The researcher(s) will code
the behavioural change techniques applied during the
sermon using a standardised coding fidelity index.
Process evaluation data analysis
Quantitative data analysis The quantitative data from
the short process evaluation questionnaires will be
analysed using descriptive statistics.
Qualitative data analysis The qualitative data from the
short process evaluation questionnaires will be analysed
using content analysis [44]. Interviews with imams and
khatibs will be transcribed verbatim and translated into
English and analysed using the Framework approach
which is designed to address applied programme and
policy-related questions [45]. NVivo 11 software will aid
data handling. Integration of interview findings with
respective short questionnaire data will be done using a
‘triangulation protocol’ [46].
Intervention fidelity data analyses The intervention
fidelity data will be analysed descriptively.
Implementation and scale-up
Based on a recent review [47] of the success factors for
scaling up public health interventions, the implementa-
tion and scale-up phase will involve three activities:
Budget impact analysis
A budget impact analysis will be conducted using sec-
ondary data to calculate the number of households who
might benefit from the implementation of the M4bH
intervention, both with and without feedback, and the
associated cost of monitors. Based on estimates of the
numbers of households, the budget impact of providing
the M4bH intervention to all households who might
benefit, both with and without a monitor, will be esti-
mated. This component is important as it will demon-
strate the potential cost which would be taken into
account when assessing the affordability of intervention
rollout.
Monitoring framework development
A simple monitoring framework which could be effi-
ciently employed as the intervention gets disseminated
widely will be developed. An expert panel will first
examine the evaluative framework used in the effect and
economic evaluation within MCLASS II and develop a
consensus on a set of measure that could replace it dur-
ing scale-up of M4bH.
‘Way Forward’ workshop
The findings of the two activities above, as well as the
imam and khatib interviews during process evaluation,
will be presented to policy-makers, development part-
ners, and respective faith-based and civil society organi-
sations in a final ‘Way Forward’ workshop. The finalised
intervention resources will also be presented. Partici-
pants will be facilitated to consider ways to overcome
the identified blocks to implementation and to plan how
to optimise opportunities for effective scale-up.
Discussion
The MCLASS II study focusses on reducing SHS expos-
ure in homes as a means of reducing the burden of lung
diseases in LMICs. There is a need for measures to
protect non-smokers, particularly women and children
from SHS exposure within the home. This study addresses
a major evidence gap in this area, which is partly respon-
sible for no clear guidance on how to implement smoking
restrictions and protect non-smokers from SHS exposure
in homes.
The study evaluates an innovative intervention com-
prising messages to promote SFH embedded within the
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Islamic discourse and delivered by faith leaders – imams
and khatibs –to their congregations, with or without
IAQ feedback. If found to be effective in changing
smoking behaviour in homes, such an approach could
shift the existing smoking norms, i.e. reducing visibility
of smoking in social spaces and de-normalising it for
children who might otherwise take up smoking. Previous
studies in South Asia (one in Pakistan and another in
Bangladesh) showed promise in community-based ap-
proaches in reducing visibility of smoking in social
spaces and promoting SFH [48, 49]. In addition, research
findings from this study are likely to be generalisable,
particularly to those communities that are facing high
tobacco-related disease burden with similar smoking
norms, and places a high value on faith-based settings
and leaders in their public and private lives. The
intervention also lends itself for adaptation and to be
used in influencing other unhealthy behaviours through
faith-based settings resulting in improving family health
in ways that goes beyond to what is proposed here.
With IAQ measurements for 1800 households at base-
line, the study will provide a large dataset on the magni-
tude of SHS exposure within the home, as well as any key
issues around IAQ measurement, in Bangladesh. IAQ
feedback has a potential to bring about change in smoking
behaviour in or around the home for some individuals
[50], thus can complement other community-based inter-
ventions such as M4bH.
The effectiveness-implementation hybrid design uti-
lised in this study has a distinct advantage of allowing
for the gathering of data on the delivery of an interven-
tion during an effectiveness trial that inform its potential
for implementation and scaling up in the ‘real world’.
MCLASS II will be conducted with active engagement
of policy-makers, a range of implementers and target
communities. The intervention and its implementation
will be tailored to the local context, which will be in-
formed by qualitative research within target communi-
ties. A strong political will exists among policy-makers
who are fully aware of the disease burden associated
with SHS, the relevant gap in policy and its implementa-
tion, and the potential benefit of addressing SHS
exposure in homes. Their engagement and interest in
this and the other two MRC-funded studies on SFH in
Bangladesh is evidence of the priority given to this area.
Costs will be measured, economic modelling of scaling
up SFH conducted, and an efficient monitoring frame-
work developed. These are key success factors for imple-
mentation and scale-up [47]. Moreover, to enhance the
impact of the research, a robust dissemination strategy
will be offered consisting of (1) engagement with, and
contributing to, policy groups through existing member-
ship of policy advisory boards and working groups
(WHO policy advisory groups, and The International
Union against Lung Disease and Tuberculosis policy
sub-groups); (2) working with the IF and the Ministry of
Religious affairs to ensure incorporation of the M4bH
training package within imams and khatibs training
curricula; and (3) producing effective dissemination
materials, i.e. policy briefs, publications in high-impact
journals, presentations and seminars at conferences,
press releases, media reports, web-publishing, and social
media feeds. It is anticipated that the results of this
study will be published in 2020.
All these elements of the study have the potential to
influence policy and practice on tobacco control, par-
ticularly SHS exposure, in Bangladesh (Additional file 1).
Trial status
MCLASS II Protocol version 4.0, 29 May 2018. The
MCLASS II trial began on 11 April 2018 with an ex-
pected end date of July 2020. We are currently recruiting
mosques, households and participants to the study.
Recruitment is expected to be complete by the end of
October 2018.
Additional file
Additional file 1: The SPIRIT 2013 Checklist: MCLASS II trial protocol*.
(DOC 121 kb)
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involved in the relevant part of the study. The information sheets will meet
all the requirements of the local Ethics Committees in Bangladesh.
Household heads/leads will explicitly be asked to consent for the installation
of Dylos meters in their homes. Illiteracy is an issue in this study setting,
which could be an impediment to obtaining informed consent. However,
the research teams are trained in explaining research information using local
dialect and pictorial participant information sheets. Those unable to sign can
provide a thumb print impression on the consent form, an acceptable
alternative to signature in Bangladesh.
In line with the Data Protection Act and the Research Governance Framework,
all data collected will be confidential, being identified with the unique study
identification number only – assigned at the beginning of the study. Access to
the participants’ personal detail will be restricted to the necessary members of
the research team only. Monitors and auditors may also need to access the
data. Encrypted data transfer from the ARK Foundation to the University of York
will be via secure drop-off services available through the University of York. At
the end of the study, hard copies of data will be securely archived at the ARK
Foundation in Dhaka, Bangladesh, whilst the digital database will be securely
archived by the University of York, for a minimum of 5 years.
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